Arrowstreet Capital, Limited Partnership Grifols Sa Transaction History
Arrowstreet Capital, Limited Partnership
- $121 Billion
- Q3 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Grifols Sa stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 448,436 shares of GRFS stock, worth $3.51 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
448,436
Previous 143,711
212.04%
Holding current value
$3.51 Million
Previous $906,000
339.51%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding GRFS
# of Institutions
164Shares Held
140MCall Options Held
288KPut Options Held
389K-
Capital World Investors Los Angeles, CA21MShares$164 Million0.03% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA19.9MShares$156 Million2.11% of portfolio
-
Permian Investment Partners, LP New York, NY12.3MShares$96.4 Million16.06% of portfolio
-
Black Creek Investment Management Inc. Toronto, A611.1MShares$86.9 Million3.5% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny10.7MShares$83.9 Million0.05% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $5.31B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...